As shown in Fig. 6A, PTDSS1 is frequently amplified (>20%) in a variety of cancer types, including bladder cancer, breast cancer, head and neck cancer, and melanoma (Fig. 6A). This evidence concerns the gene PTDSS1 and urinary bladder carcinoma.